Publications found:
43,319
Sort by:
2017 Emerging Clinical Chemistry and Immunodiagnostic Tests, and Strategic Profiles of Leading Reagent and Instrument Suppliers
US$ 3,465.00
... 320-page report presents an overview of the clinical significance and market needs for major Chemistry, TDM, Endocrine, Cancer, Immunoprotein, and Abused ... . The report also presents strategic assessments of current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market shares, product ...
January 2017
320 pages
2017 Emerging Transfusion Diagnostic Typing, Grouping and NAT Screening Tests, and Strategic Profiles and Leading Reagent and Instrument Suppliers
US$ 3,465.00
... analysis of the clinical significance and market needs for major transfusion diagnostic typing, grouping, and infectious disease screening assays, including NAT ... . The report also presents strategic assessments of current and emerging suppliers, including their sales, product portfolios, marketing tactics, ...
January 2017
225 pages
2017 Emerging Tumor Markers, and Strategic Profiles of Leading Reagent and Instrument Suppliers
US$ 3,465.00
... major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical ... clinical significance and market needs for both current and emerging tumor markers, as well as extensive listings of companies, universities and research centers developing ...
January 2017
286 pages
2017-2021 France Enteric Disease Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technologies
US$ 1,980.00
... report from VPGMarketResearch.com presents detailed analysis of the French Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium ... technologies and products; and- Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
322 pages
2017-2021 Germany Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 1,755.00
... report from VPGMarketResearch.com presents detailed analysis of the German Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza ... technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
283 pages
2017-2021 Germany Enteric Disease Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 1,980.00
... report from VPGMarketResearch.com presents detailed analysis of the German Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium ... technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
322 pages
2017-2021 Italy Enteric Disease Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 1,980.00
... report from VPGMarketResearch.com presents detailed analysis of the Italian Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium ... technologies and products; and- Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
322 pages
2017-2021 Japan Enteric Disease Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 2,340.00
... report from VPGMarketResearch.com presents detailed analysis of the Japanese Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium ... technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
322 pages
2017-2021 Spain Enteric Disease Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 1,980.00
... report from VPGMarketResearch.com presents detailed analysis of the Spanish Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium ... technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
322 pages
2017-2021 UK Enteric Disease Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 1,980.00
... -page report from VPGMarketResearch.com presents detailed analysis of the UK Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium ... technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
322 pages
2017-2021 US Enteric Disease Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 3,465.00
... -page report from VPGMarketResearch.com presents detailed analysis of the US Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium ... technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
322 pages
2017-2021 France Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 1,755.00
... report from VPGMarketResearch.com presents detailed analysis of the French Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza ... technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
282 pages
2017-2021 Italy Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 1,755.00
... report from VPGMarketResearch.com presents detailed analysis of the Italian Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza ... technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
281 pages
2017-2021 Japan Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 2,160.00
... report from VPGMarketResearch.com presents detailed analysis of the Japanese Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza ... technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
282 pages
2017-2021 Spain Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 1,755.00
... report from VPGMarketResearch.com presents detailed analysis of the Spanish Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza ... technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
281 pages
2017-2021 UK Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 1,755.00
... -page report from VPGMarketResearch.com presents detailed analysis of the UK Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza ... technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
281 pages
2017-2021 US Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 3,240.00
... -page report from VPGMarketResearch.com presents detailed analysis of the US Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza ... technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
283 pages
2017-2021 US HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts
US$ 1,305.00
... and sale forecasts for HIV-1/2/combo, HIV Ag, NAT, Western Blot and other confirmatory assays performed in the following market segments: Hospitals ... sales and market Share estimates for major suppliers of AIDS testing including Abbott, bioMerieux, Bio-Rad, Grifols, Ortho Clinical Diagnostics, and Roche ...
January 2017
2017-2021 UK HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts
US$ 1,305.00
... and sale forecasts for HIV-1/2/Combo, HIV Ag, NAT, Western Blot and other confirmatory assays performed in the following market segments: Hospitals ... sales and market share estimates for major suppliers of AIDS tests, including Abbott, bioMerieux, Bio-Rad, Grifols, Ortho Clinical Diagnostics/J&J, Roche, and ...
January 2017
2017-2021 Spain HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts
US$ 1,305.00
... and sale forecasts for HIV-1/2/Combo, HIV Ag, NAT, Western Blot and other confirmatory assays performed in the following market segments: Hospitals ... and market share estimates for major suppliers of AIDS tests, including Abbott, Biokit, bioMerieux, Bio-Rad, Fujirebio, Grifols, Ortho Clinical Diagnostics/J&J, ...
January 2017
2017-2021 Japan HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts
US$ 1,305.00
... sale forecasts for HIV-1/2/Combo, HIV Ag, NAT, Western Blot and other confirmatory assays performed in the following market segments: Hospitals ... sales and market share estimates for major suppliers of AIDS tests, including Abbott, bioMerieux, Fujirebio, Grifols, Ortho Clinical Diagnostics/J&J, Roche, ...
January 2017
2017-2021 Italy HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts
US$ 1,305.00
... and sale forecasts for HIV-1/2/Combo, HIV Ag, NAT, Western Blot and other confirmatory assays performed in the following market segments: Hospitals ... sales and market share estimates for major suppliers of AIDS tests, including Abbott, bioMerieux, Bio-Rad, DiaSorin, Grifols, Ortho Clinical Diagnostics/J&J, ...
January 2017
2017-2021 Germany HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts
US$ 1,305.00
... and sale forecasts for HIV-1/2/Combo, HIV Ag, NAT, Western Blot, and other confirmatory assays performed in the following market segments: Hospitals ... and market share estimates for major suppliers of AIDS tests, including Abbott, Biotest, bioMerieux, Bio-Rad, DiaSorin, Grifols, Ortho Clinical Diagnostics/J&J, ...
January 2017
2017-2021 France HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts
US$ 1,305.00
... sale forecasts for HIV-1/2/Combo, HIVAg, NAT, Western Blot, and other confirmatory assays performed in the following market segments: Hospitals ... sales and market share estimates for major suppliers of AIDS tests, including Abbott, Biotest, bioMerieux, Bio-Rad, Grifols, Ortho Clinical Diagnostics/J&J, Roche ...
January 2017
